Professor MinWoo Kim’s research team newest development, MoGLo-Net, solves the extensive 3D imaging problems. MoGLo-Net is a deep learning model that automatically tracks transducer movements without ...

The SVP of educational development’s contribution to the book displays SKNV’s approach to furthering education and ...

Pharmaceutical Executive recently spoke with RheumaGen CEO Richard Freed about his career and the work the biotech is doing ...

Health services company Humana announced its first Humana Cognitive Games. 1 The event is designed to give older adults both ...

Corina Dutcus, SVP, oncology global clinical development lead at Eisai, discusses the potential of the E7386 and lenvatinib ...

The newly approved prefilled syringe version of Shingrix is expected to simplify administration and supports efforts to ...

Priority review was based on results from the Phase IIb SunRISe-1 trial, which showed that patients treated with TAR-200 for ...

Research from a recent Cadent study reveals the growing impact of TV and connected TV advertising in raising medication ...

The reality TV star and certified obesity physician Dr. Holly Lofton plan to use the show to further educate GLP-1 users on ...

Corina Dutcus, SVP, oncology global clinical development lead, Eisai, explains how E7386 and lenvatinib work together to ...

Industry experts react to the developer’s role in preparing for value-based contracting, acknowledging that innovative agreements can support access when evidence is still maturing.

Corina Dutcus, SVP, oncology global clinical development lead, Eisai, highlights how long-term LEAP-002 data provides critical reassurance around Lenvima’s durability and safety in treating ...